The S2 subsites of cathepsins K and L and their contribution to collagen degradation

Protein Science

Volumn 16, Issue 4, 2007, Pages 662-670

  Lecaille, Fabien ^a,b,c   Chowdhury, Shafinaz ^d   Purisima, Enrico ^e   Brömme, Dieter ^f   Lalmanach, Gilles ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c IFR 135   (France)

^d MCGILL UNIVERSITY   (Canada)

^e NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cathepsin; Collagen; Cysteine protease; Peptide inhibitor; Substrate specificity

Indexed keywords

1 (N BENZYLOXYCARBONYL LEUCYL) 5 (N BOC PHENYLALANYL LEUCYL)CARBOHYDRAZIDE; AMIDE; CATHEPSIN K; CATHEPSIN L; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 4; CONGO RED; ELASTIN; HYDRAZIDE DERIVATIVE; N (4 BIPHENYLACETYL) S METHYLCYSTEINE (D) ARG PHE BETA PHENETHYLAMIDE; UNCLASSIFIED DRUG;

ARTICLE; COLLAGEN DEGRADATION; ENZYME SPECIFICITY; KINETICS; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SITE DIRECTED MUTAGENESIS;

CATHEPSINS; COLLAGEN; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HYDROLYSIS; SUBSTRATE SPECIFICITY;

EID: 33947718470     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.062666607     Document Type: Article

References (43)

1. Aibe, K., Yazawa, H., Abe, K., Teramura, K., Kumegawa, M., Kawashima, H., and Honda, K. 1996. Substrate specificity of recombinant osteoclast-specific cathepsin K from rabbits. Biol. Pharm. Bull. 19: 1026-1031.
2. Barrett, A.J., Kembhavi, A.A., Brown, M.A., Kirschke, H., Knight, C.G., Tamai, M., and Hanada, K. 1982. L-Trans-epoxysuccinyl-leucylamido(4-guanidino) butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem. J. 201: 189-198.
3. Brömme, D. and Kaleta, J. 2002. Thiol-dependent cathepsins: Pathophysiological implications and recent advances in inhibitor design. Curr. Pharm. Des. 8: 1639-1658.
4. Brömme, D., Klaus, J.L., Okamoto, K., Rasnick, D., and Palmer, J.T. 1996. Peptidyl vinyl sulphones: A new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L. Biochem. J. 315: 85-89.
5. Bühling, F., Rocken, C., Brasch, F., Hartig, R., Yasuda, Y., Saftig, P., Brömme, D., and Welte, T. 2004. Pivotal role of cathepsin K in lung fibrosis. Am. J. Pathol. 164: 2203-2216.
6. Chapman Jr., H.A. and Shi, G.P. 2000. Protease injury in the development of COPD: Thomas A. Neff Lecture. Chest 117: 295S-299S.
7. Chapman, H.A., Riese, R.J., and Shi, G.P. 1997. Emerging roles for cysteine proteases in human biology. Annu. Rev. Physiol. 59: 63-88.
8. Choe, Y., Leonetti, F., Greenbaum, D.C., Lecaille, F., Bogyo, M., Brömme, D., Ellman, J.A., and Craik, C.S. 2006. Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities. J. Biol. Chem. 281: 12824-12832.
9. Chowdhury, S.F., Sivaraman, J., Wang, J., Devanathan, G., Lachance, P., Qi, H., Menard, R., Lefebvre, J., Konishi, Y., Cygler, M., et al. 2002. Design of noncovalent inhibitors of human cathepsin L. From the 96-residue proregion to optimized tripeptides. J. Med. Chem. 45: 5321-5329.
10. Cornell, W.D., Cieplak, P., Bayly, C.I., Gould, I.R., Merz Jr., K.M., Ferguson, D.M., Spellmeyer, D.C., Fox, T., Caldwell, J.W., and Kollman, P.A. 1995. A second generation force field for the simulation of proteins, nucleic acids and organic molecules. J. Am. Chem. Soc. 117: 5179-5197.
11. Garnero, P., Borel, O., Byrjalsen, I., Ferreras, M., Drake, F.H., McQueney, M.S., Foged, N.T., Delmas, P.D., and Delaisse, J.M. 1998. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J. Biol. Chem. 273: 32347-32352.
12. Godat, E., Lecaille, F., Desmazes, C., Duchene, S., Weidauer, E., Saftig, P., Brömme, D., Vandier, C., and Lalmanach, G. 2004. Cathepsin K: A cysteine protease with unique kinin-degrading properties. Biochem. J. 383: 501-506.
13. Joyce, J.A. and Hanahan, D. 2004. Multiple roles for cysteine cathepsins in cancer. Cell Cycle 3: 1516-1519.
14. Kafienah, W., Brömme, D., Buttle, D.J., Croucher, L.J., and Hollander, A.P. 1998. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem. J. 331: 727-732.
15. Lecaille, F., Kaleta, J., and Brömme, D. 2002a. Human and parasitic papain-like cysteine proteases: Their role in physiology and pathology and recent developments in inhibitor design. Chem. Rev. 102: 4459-4488.
16. Lecaille, F., Choe, Y., Brandt, W., Li, Z., Craik, C.S., and Brömme, D. 2002b. Selective inhibition of the collagenolytic activity of human cathepsin K by altering its S2 subsite specificity. Biochemistry 41: 8447-8454.
17. Lecaille, F., Vandier, C., Godat, E., Hervé-Grépinet, V., Brömme, D., and Lalmanach, G. 2007. Modulation of hypotensive effects of kinins by cathepsin K. Arch. Biochem. Biophys 459: 129-136.
18. Li, Z. and Scheraga, H.A. 1987. Monte Carlo-minimization approach to the multiple-minima problem in protein folding. Proc. Natl. Acad. Sci. 84: 6611-6615.
19. Li, Z., Hou, W.S., and Brömme, D. 2000. Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates. Biochemistry 39: 529-536.
20. Li, Z., Hou, W.S., Escalante-Torres, C.R., Gelb, B.D., and Brömme, D. 2002. Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate. J. Biol. Chem. 277: 28669-28676.
21. Li, Z., Yasuda, Y., Li, W., Bogyo, M., Katz, N., Gordon, R.E., Fields, G.B., and Brömme, D. 2004. Regulation of collagenase activities of human cathepsins by glycosaminoglycans. J. Biol. Chem. 279: 5470-5479.
22. Nägler, D.K. and Menard, R. 2003. Family C1 cysteine proteases: Biological diversity or redundancy? Biol. Chem. 384: 837-843.
23. Naim, M., Bhat, S., Rankin, K.N., Dennis, S., Chowdhury, S.F., Siddiqi, I., Drabik, P., Sulea, T., Bayly, C.I., Jakalian, A., et al. 2007. Solvated interation Energy (SIE) for scoring protein-ligand binding affinities. I. Exploring the parameter space. J. Chem. Inf. Model. 47: 122-133.
24. Nicklin, M.J. and Barrett, A.J. 1984. Inhibition of cysteine proteinases and dipeptidyl peptidase I by egg-white cystatin. Biochem. J. 223: 245-253.
25. Ortega, M.M., Nascimento, H., Costa, F.F., Teori, M.T., and Lima, C.S. 2003. A polymorphism in the angiogenesis inhibitor, endostatin, in multiple myeloma. Leuk. Res. 27: 93-94.
26. Prockop, D.J. and Kivirikko, K.I. 1995. Collagens: Molecular biology, diseases, and potentials for therapy. Annu. Rev. Biochem. 64: 403-434.
27. Purisima, E.O. 1998. Fast summation boundary element methods for calculating solvation free energies of macromolecules. J. Comput. Chem. 19: 1494-1505.
28. Purisima, E.O. and Nilar, S.H. 1995. A simple yet accurate boundary element method for continuum dielectric calculations. J. Comput. Chem. 16: 681-689.
29. Puzer, L., Vercesi, J., Alves, M.F., Barros, N.M., Araujo, M.S., Aparecida Juliano, M., Reis, M.L., Juliano, L., and Carmona, A.K. 2005. A possible alternative mechanism of kinin generation in vivo by cathepsin L. Biol. Chem. 386: 699-704.
30. Rawlings, N.D., Morton, F.R., and Barrett, A.J. 2006. MEROPS: The peptidase database. Nucleic Acids Res. 34: D270-D272.
31. Riese, R.J. and Chapman, H.A. 2000. Cathepsins and compartmentalization in antigen presentation. Curr. Opin. Immunol. 12: 107-113.
32. Roth, W., Deussing, J., Botchkarev, V.A., Pauly-Evers, M., Saftig, P., Hafner, A., Schmidt, P., Schmahl, W., Scherer, J., Anton-Lamprecht, I., et al. 2000. Cathepsin L deficiency as molecular defect of furless: Hyperproliferation of keratinocytes and perturbation of hair follicle cycling. FASEB J. 14: 2075-2086.
33. Smooker, P.M., Whisstock, J.C., Irving, J.A., Siyaguna, S., Spithill, T.W., and Pike, R.N. 2000. A single amino acid substitution affects substrate specificity in cysteine proteinases from Fasciola hepatica. Protein Sci. 9: 2567-2572.
34. Taleb, S., Lacasa, D., Bastard, J.P., Poitou, C., Cancello, R., Pelloux, V., Viguerie, N., Benis, A., Zucker, J.D., Bouillot, J.L., et al. 2005. Cathepsin S, a novel biomarker of adiposity: Relevance to atherogenesis. FASEB J. 19: 1540-1542.
35. Tepel, C., Brömme, D., Herzog, V., and Brix, K. 2000. Cathepsin K in thyroid epithelial cells: Sequence, localization and possible function in extracellular proteolysis of thyroglobulin. J. Cell Sci. 113: 4487-4498.
36. Thompson, S.K., Halbert, S.M., Bossard, M.J., Tomaszek, T.A., Levy, M.A., Zhao, B., Smith, W.W., Abdel-Meguid, S.S., Janson, C.A., D'Alessio, K.J., et al. 1997. Design of potent and selective human cathepsin K inhibitors that span the active site. Proc. Natl. Acad. Sci. 94: 14249-14254.
37. Turk, V., Turk, B., and Turk, D. 2001. Lysosomal cysteine proteases: Facts and opportunities. EMBO J. 20: 4629-4633.
38. Wang, D., Pechar, M., Li, W., Kopeckova, P., Brömme, D., and Kopecek, J. 2002. Inhibition of cathepsin K with lysosomotropic macromolecular inhibitors. Biochemistry 41: 8849-8859.
39. Williams, J.W. and Morrison, J.F. 1979. The kinetics of reversible tight-binding inhibition. Methods Enzymol. 63: 437-467.
40. Word, J.M., Lovell, S.C., Richardson, J.S., and Richardson, D.C. 1999. Asparagine and glutamine: Using hydrogen atom contacts in the choice of side-chain amide orientation. J. Mol. Biol. 285: 1735-1747.
41. Xia, L., Kilb, J., Wex, H., Lipyansky, A., Breuil, V., Stein, L., Palmer, J.T., Dempster, D.W., and Brömme, D. 1999. Localization of rat cathepsin K in osteoclasts and resorption pits: Inhibition of bone resorption cathepsin K-activity by peptidyl vinyl sulfones. Biol. Chem. 380: 679-687.
42. Yasothornsrikul, S., Greenbaum, D., Medzihradszky, K.F., Toneff, T., Bundey, R., Miller, R., Schilling, B., Petermann, I., Dehnert, J., Logvinova, A., et al. 2003. Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter. Proc. Natl. Acad. Sci. 100: 9590-9595.
43. Yasuda, Y., Li, Z., Greenbaum, D., Bogyo, M., Weber, E., and Brömme, D. 2004. Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages. J. Biol. Chem. 279: 36761-36770.